Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
about
Toremifene versus tamoxifen for advanced breast cancerToremifene versus tamoxifen for advanced breast cancerEndocrinology and hormone therapy in breast cancer: selective oestrogen receptor modulators and downregulators for breast cancer - have they lost their way?Toremifene in the treatment of breast cancerProtective effects of estrogen in a rat model of age-related cataracts.Is there a growing role for endocrine therapy in the treatment of breast cancer?The Role of Hormonal Therapy in Breast Cancer.A comparison of survival outcomes and side effects of toremifene or tamoxifen therapy in premenopausal estrogen and progesterone receptor positive breast cancer patients: a retrospective cohort studyRaloxifene and its role in breast cancer prevention.Cardiotoxicity of molecularly targeted agentsEstrogen receptor modulators and down regulators: optimal use in postmenopausal women with breast cancer.Estrogen protects against radiation-induced cataractogenesisEffects of toremifene versus tamoxifen on breast cancer patients: a meta-analysis.Selective estrogen receptor modulators in clinical practice: a safety overview.Clinical Implications of the Progression-Free Survival Endpoint for Treatment of Hormone Receptor-Positive Advanced Breast Cancer.Drug resistance in chemotherapy for breast cancer.Excellent outcomes with adjuvant toremifene or tamoxifen in early stage breast cancer.Phase III randomized trial of toremifene vs tamoxifen in hormonodependant advanced breast cancer.Tolerability of hormone therapies for breast cancer: how informative are documented symptom profiles in medical notes for 'well-tolerated' treatments?Estrogenic effects of toremifene and tamoxifen in postmenopausal breast cancer patients.Role and pharmacologic significance of cytochrome P-450 2D6 in oxidative metabolism of toremifene and tamoxifen.Phase III randomized trial of toremifene versus tamoxifen for Japanese postmenopausal patients with early breast cancer.Pharmacokinetic analysis of a combined chemoendocrine treatment with paclitaxel and toremifene for metastatic breast cancer.Bone mineral density and lipid changes during 5 years of follow-up in a study of prevention of breast cancer with toremifene in healthy, high-risk pre- and post-menopausal women.Genotoxicity studies with the antiestrogen toremifene.Effects of high dose raloxifene in selected patients with advanced breast carcinoma.New Hormonal Therapies for Breast Cancer.Therapeutic options for metastatic breast cancer
P2860
Q24202053-923B332F-C70B-4FCA-939A-8A4E6652955BQ24235404-8BE99DB3-2C7D-440A-A188-026B9BE35613Q24810287-B779B6C4-17F5-49D1-A5C2-1328BB72C943Q27010309-7B7B4941-8AD0-484B-AA8A-1EF9B3D6EEC9Q30748551-73BF9BC6-3850-422E-94B4-B53363E64368Q33993658-1EE8D7A3-2579-4470-97E5-FA48D0B06C43Q34089338-85F68CE7-F515-4D2F-BDBE-DC50CCC93232Q34252972-D340C159-92ED-47CC-AC6C-3FC9FF52E545Q35843668-9430DF52-8270-4A30-BBEF-10D2FF95F5F6Q35878459-833E3547-5D5B-4F01-B931-BA9ADBB003BAQ36993383-773B5F39-EA97-465D-9364-56051EDEC8C0Q37061745-62339021-5260-40DA-8E43-67414156A4B1Q38069795-55F3DE95-2F99-4179-8DAC-E6A1E224E33BQ38455538-1F46B097-8F2D-4988-89B5-5D4323E7E419Q38852355-2AC627D1-1C78-4FA8-A4FF-B088BB562B70Q40353870-A654310E-E62B-46E5-88D8-4090F01DFE85Q43139826-96DE57F0-64F0-4FB5-A755-89FA8852DEAFQ43549607-273C1FD3-678C-46F0-8BC9-F034E60E1FEAQ43614271-E376286E-FFED-4852-89B7-ABE97098C152Q44704123-9755AD59-0001-475B-AD20-FF6EECD44B06Q45394201-0363D98C-11B5-4339-8D84-553B2A193A71Q46166289-48FC1F68-E318-408D-BFFD-C4241DD20347Q46307920-3FB0C5E4-E33A-49C1-863B-235451180D35Q46711901-EDAE375B-6DB5-41D7-9DD6-106006BAC087Q50128526-C89672B8-6C48-4F94-BDB8-5188C628AAFBQ53521747-4109186E-3B68-46DC-B722-B96B0769641DQ54056103-183ADB4F-2860-4210-B7FA-2EB3CDA5A561Q57142375-40158545-5DC3-49BA-BBEA-DA713F243725
P2860
Comparison of toremifene and tamoxifen in post-menopausal patients with advanced breast cancer: a randomized double-blind, the 'nordic' phase III study.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Comparison of toremifene and t ...... the 'nordic' phase III study.
@ast
Comparison of toremifene and t ...... the 'nordic' phase III study.
@en
type
label
Comparison of toremifene and t ...... the 'nordic' phase III study.
@ast
Comparison of toremifene and t ...... the 'nordic' phase III study.
@en
prefLabel
Comparison of toremifene and t ...... the 'nordic' phase III study.
@ast
Comparison of toremifene and t ...... the 'nordic' phase III study.
@en
P2093
P2860
P356
P1476
Comparison of toremifene and t ...... the 'nordic' phase III study.
@en
P2093
Gundersen S
Hietanen T
Pawlicki M
Pienkowski T
P2860
P2888
P304
P356
10.1038/BJC.1997.375
P407
P577
1997-01-01T00:00:00Z